Hemophilia treatment. Immune tolerance induction: treatment duration analysis and economic considerations.
Louis M. Aledort(Icahn School of Medicine at Mount Sinai), Guglielmo Mariani, Barbara L. Kroner(RTI International)
PubMed
October 1, 2000
Cited by 12
Related Papers
Standards for epidemiologic studies and surveillance of epilepsy
|Epilepsia|2011|1k
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Definitions in Hemophilia
|Thrombosis and Haemostasis|2001|772
A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs
|Journal of Internal Medicine|1994|613